HHS Opens New Office to Study Prolonged COVID Response, NIH Begins Clinical Trials

WATCH LIVE

The Biden administration announced Monday that it is forming a new office of studies and practice on long COVID to investigate the disease and people diagnosed with it.

The office, which will report to the Department of Health and Human Services, “is for the ongoing coordination of government-wide reaction to the long-term effects of COVID-19,” according to a press release.

“The Office of COVID Research and Long Practice will make efforts across the U. S. government. “We are looking forward to improving the lives of those who continue to suffer the long-term effects of the worst public fitness crisis in a century,” HHS Secretary Adm. Rachel said Levine. in a report.

“Bringing together the resources and expertise of federal, state and local partners, patients, providers, researchers and the corporate sector to answer the most pressing calls to action from the American people,” Levine said.

Long COVID is a condition where patients still have symptoms at least 4 weeks after clearing the infection. In some cases, symptoms may be felt for months or years.

HHS estimates that between 7. 7 million and 23 million Americans have developed a long COVID after becoming inflamed with the virus.

Symptoms vary and can present with fatigue, shortness of breath, headaches, mental confusion, joint and muscle pain, and ongoing loss of taste and smell, according to the Centers for Disease Control and Prevention.

A CDC survey last year found that 81% of adults with persistent COVID symptoms for 3 months or more, or 4 out of five adults, enjoy limitations in their activities compared to before having the virus. In addition, 25% reported limitations.

It’s unclear what drives others to spread prolonged COVID, but studies are ongoing.

HHS also announced Monday that the National Institutes of Health is launching prolonged COVID clinical trials through the RECOVER initiative, which seeks to understand, treat, and save you from the long COVID.

The new clinical trials will explore conceivable remedies for excessive fatigue, sleep disorders, changes in physical functions and cognitive dysfunctions.

“As our country continues to make progress in the fight against COVID-19, it is very important that we address the effects of prolonged COVID-19 and provide resources to those who need them,” HHS Secretary Xavier Becerra said in a statement. declaration. ” Last year, President Biden asked HHS to coordinate the response to Long COVID. The formal status quo of the Long COVID Coordination Office and the launch of the RECOVER clinical trials reinforce this factor as an ongoing priority. “

Dog Treated with Narcan After Imaginable Fentanyl Exposure in SF Park

$1. 05 billion Mega Millions jackpot for numbers drawn on Tuesday

U. S. advances to Women’s World Cup knockout round after goalless draw

Leave a Comment

Your email address will not be published. Required fields are marked *